+1 (704) 266-3234

Global Synthetic Opioids Market Insights And Forecast To 2028

Published on: Feb 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 105

Synthetic Opioids market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Synthetic Opioids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Methadone
Fentanyl
Meperidine
Hydrocodone
Oxymorphone
Oxycodone
Segment by Application
Pain Management
De-addiction
By Company
Purdue Pharma
Pfizer
Janssen Pharmaceuticals
Teva Pharmaceuticals
Endo International
West-Ward Pharmaceuticals
Mallinckrodt Pharmaceuticals
Mylan
Impax Laboratories
Indivior
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

1 Study Coverage
1.1 Synthetic Opioids Product Introduction
1.2 Market by Type
1.2.1 Global Synthetic Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Methadone
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Hydrocodone
1.2.6 Oxymorphone
1.2.7 Oxycodone
1.3 Market by Application
1.3.1 Global Synthetic Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pain Management
1.3.3 De-addiction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Synthetic Opioids Sales Estimates and Forecasts 2017-2028
2.2 Global Synthetic Opioids Revenue Estimates and Forecasts 2017-2028
2.3 Global Synthetic Opioids Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Synthetic Opioids Sales by Region
2.4.1 Global Synthetic Opioids Sales by Region (2017-2022)
2.4.2 Global Sales Synthetic Opioids by Region (2023-2028)
2.5 Global Synthetic Opioids Revenue by Region
2.5.1 Global Synthetic Opioids Revenue by Region (2017-2022)
2.5.2 Global Synthetic Opioids Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Synthetic Opioids Sales by Manufacturers
3.1.1 Global Top Synthetic Opioids Manufacturers by Sales (2017-2022)
3.1.2 Global Synthetic Opioids Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Synthetic Opioids in 2021
3.2 Global Synthetic Opioids Revenue by Manufacturers
3.2.1 Global Synthetic Opioids Revenue by Manufacturers (2017-2022)
3.2.2 Global Synthetic Opioids Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Synthetic Opioids Revenue in 2021
3.3 Global Synthetic Opioids Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Synthetic Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Synthetic Opioids Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Synthetic Opioids Sales by Type
4.1.1 Global Synthetic Opioids Historical Sales by Type (2017-2022)
4.1.2 Global Synthetic Opioids Forecasted Sales by Type (2023-2028)
4.1.3 Global Synthetic Opioids Sales Market Share by Type (2017-2028)
4.2 Global Synthetic Opioids Revenue by Type
4.2.1 Global Synthetic Opioids Historical Revenue by Type (2017-2022)
4.2.2 Global Synthetic Opioids Forecasted Revenue by Type (2023-2028)
4.2.3 Global Synthetic Opioids Revenue Market Share by Type (2017-2028)
4.3 Global Synthetic Opioids Price by Type
4.3.1 Global Synthetic Opioids Price by Type (2017-2022)
4.3.2 Global Synthetic Opioids Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Synthetic Opioids Sales by Application
5.1.1 Global Synthetic Opioids Historical Sales by Application (2017-2022)
5.1.2 Global Synthetic Opioids Forecasted Sales by Application (2023-2028)
5.1.3 Global Synthetic Opioids Sales Market Share by Application (2017-2028)
5.2 Global Synthetic Opioids Revenue by Application
5.2.1 Global Synthetic Opioids Historical Revenue by Application (2017-2022)
5.2.2 Global Synthetic Opioids Forecasted Revenue by Application (2023-2028)
5.2.3 Global Synthetic Opioids Revenue Market Share by Application (2017-2028)
5.3 Global Synthetic Opioids Price by Application
5.3.1 Global Synthetic Opioids Price by Application (2017-2022)
5.3.2 Global Synthetic Opioids Price Forecast by Application (2023-2028)
6 North America
6.1 North America Synthetic Opioids Market Size by Type
6.1.1 North America Synthetic Opioids Sales by Type (2017-2028)
6.1.2 North America Synthetic Opioids Revenue by Type (2017-2028)
6.2 North America Synthetic Opioids Market Size by Application
6.2.1 North America Synthetic Opioids Sales by Application (2017-2028)
6.2.2 North America Synthetic Opioids Revenue by Application (2017-2028)
6.3 North America Synthetic Opioids Market Size by Country
6.3.1 North America Synthetic Opioids Sales by Country (2017-2028)
6.3.2 North America Synthetic Opioids Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Synthetic Opioids Market Size by Type
7.1.1 Europe Synthetic Opioids Sales by Type (2017-2028)
7.1.2 Europe Synthetic Opioids Revenue by Type (2017-2028)
7.2 Europe Synthetic Opioids Market Size by Application
7.2.1 Europe Synthetic Opioids Sales by Application (2017-2028)
7.2.2 Europe Synthetic Opioids Revenue by Application (2017-2028)
7.3 Europe Synthetic Opioids Market Size by Country
7.3.1 Europe Synthetic Opioids Sales by Country (2017-2028)
7.3.2 Europe Synthetic Opioids Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Synthetic Opioids Market Size by Type
8.1.1 Asia Pacific Synthetic Opioids Sales by Type (2017-2028)
8.1.2 Asia Pacific Synthetic Opioids Revenue by Type (2017-2028)
8.2 Asia Pacific Synthetic Opioids Market Size by Application
8.2.1 Asia Pacific Synthetic Opioids Sales by Application (2017-2028)
8.2.2 Asia Pacific Synthetic Opioids Revenue by Application (2017-2028)
8.3 Asia Pacific Synthetic Opioids Market Size by Region
8.3.1 Asia Pacific Synthetic Opioids Sales by Region (2017-2028)
8.3.2 Asia Pacific Synthetic Opioids Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Synthetic Opioids Market Size by Type
9.1.1 Latin America Synthetic Opioids Sales by Type (2017-2028)
9.1.2 Latin America Synthetic Opioids Revenue by Type (2017-2028)
9.2 Latin America Synthetic Opioids Market Size by Application
9.2.1 Latin America Synthetic Opioids Sales by Application (2017-2028)
9.2.2 Latin America Synthetic Opioids Revenue by Application (2017-2028)
9.3 Latin America Synthetic Opioids Market Size by Country
9.3.1 Latin America Synthetic Opioids Sales by Country (2017-2028)
9.3.2 Latin America Synthetic Opioids Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Synthetic Opioids Market Size by Type
10.1.1 Middle East and Africa Synthetic Opioids Sales by Type (2017-2028)
10.1.2 Middle East and Africa Synthetic Opioids Revenue by Type (2017-2028)
10.2 Middle East and Africa Synthetic Opioids Market Size by Application
10.2.1 Middle East and Africa Synthetic Opioids Sales by Application (2017-2028)
10.2.2 Middle East and Africa Synthetic Opioids Revenue by Application (2017-2028)
10.3 Middle East and Africa Synthetic Opioids Market Size by Country
10.3.1 Middle East and Africa Synthetic Opioids Sales by Country (2017-2028)
10.3.2 Middle East and Africa Synthetic Opioids Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Corporation Information
11.1.2 Purdue Pharma Overview
11.1.3 Purdue Pharma Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Purdue Pharma Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Purdue Pharma Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Corporation Information
11.3.2 Janssen Pharmaceuticals Overview
11.3.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Janssen Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Janssen Pharmaceuticals Recent Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Corporation Information
11.4.2 Teva Pharmaceuticals Overview
11.4.3 Teva Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Pharmaceuticals Recent Developments
11.5 Endo International
11.5.1 Endo International Corporation Information
11.5.2 Endo International Overview
11.5.3 Endo International Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Endo International Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Endo International Recent Developments
11.6 West-Ward Pharmaceuticals
11.6.1 West-Ward Pharmaceuticals Corporation Information
11.6.2 West-Ward Pharmaceuticals Overview
11.6.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 West-Ward Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 West-Ward Pharmaceuticals Recent Developments
11.7 Mallinckrodt Pharmaceuticals
11.7.1 Mallinckrodt Pharmaceuticals Corporation Information
11.7.2 Mallinckrodt Pharmaceuticals Overview
11.7.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mallinckrodt Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mallinckrodt Pharmaceuticals Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Impax Laboratories
11.9.1 Impax Laboratories Corporation Information
11.9.2 Impax Laboratories Overview
11.9.3 Impax Laboratories Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Impax Laboratories Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Impax Laboratories Recent Developments
11.10 Indivior
11.10.1 Indivior Corporation Information
11.10.2 Indivior Overview
11.10.3 Indivior Synthetic Opioids Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Indivior Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Indivior Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Synthetic Opioids Industry Chain Analysis
12.2 Synthetic Opioids Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Synthetic Opioids Production Mode & Process
12.4 Synthetic Opioids Sales and Marketing
12.4.1 Synthetic Opioids Sales Channels
12.4.2 Synthetic Opioids Distributors
12.5 Synthetic Opioids Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Synthetic Opioids Industry Trends
13.2 Synthetic Opioids Market Drivers
13.3 Synthetic Opioids Market Challenges
13.4 Synthetic Opioids Market Restraints
14 Key Findings in The Global Synthetic Opioids Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Synthetic Opioids Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Methadone
Table 3. Major Manufacturers of Fentanyl
Table 4. Major Manufacturers of Meperidine
Table 5. Major Manufacturers of Hydrocodone
Table 6. Major Manufacturers of Oxymorphone
Table 7. Major Manufacturers of Oxycodone
Table 8. Global Synthetic Opioids Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Synthetic Opioids Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Synthetic Opioids Sales by Region (2017-2022) & (K Pcs)
Table 11. Global Synthetic Opioids Sales Market Share by Region (2017-2022)
Table 12. Global Synthetic Opioids Sales by Region (2023-2028) & (K Pcs)
Table 13. Global Synthetic Opioids Sales Market Share by Region (2023-2028)
Table 14. Global Synthetic Opioids Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Synthetic Opioids Revenue Market Share by Region (2017-2022)
Table 16. Global Synthetic Opioids Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Synthetic Opioids Revenue Market Share by Region (2023-2028)
Table 18. Global Synthetic Opioids Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global Synthetic Opioids Sales Share by Manufacturers (2017-2022)
Table 20. Global Synthetic Opioids Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Synthetic Opioids Revenue Share by Manufacturers (2017-2022)
Table 22. Synthetic Opioids Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global Synthetic Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Synthetic Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Opioids as of 2021)
Table 25. Synthetic Opioids Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Synthetic Opioids Product Offered
Table 27. Date of Manufacturers Enter into Synthetic Opioids Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Synthetic Opioids Sales by Type (2017-2022) & (K Pcs)
Table 30. Global Synthetic Opioids Sales by Type (2023-2028) & (K Pcs)
Table 31. Global Synthetic Opioids Sales Share by Type (2017-2022)
Table 32. Global Synthetic Opioids Sales Share by Type (2023-2028)
Table 33. Global Synthetic Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Synthetic Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Synthetic Opioids Revenue Share by Type (2017-2022)
Table 36. Global Synthetic Opioids Revenue Share by Type (2023-2028)
Table 37. Synthetic Opioids Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global Synthetic Opioids Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global Synthetic Opioids Sales by Application (2017-2022) & (K Pcs)
Table 40. Global Synthetic Opioids Sales by Application (2023-2028) & (K Pcs)
Table 41. Global Synthetic Opioids Sales Share by Application (2017-2022)
Table 42. Global Synthetic Opioids Sales Share by Application (2023-2028)
Table 43. Global Synthetic Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Synthetic Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Synthetic Opioids Revenue Share by Application (2017-2022)
Table 46. Global Synthetic Opioids Revenue Share by Application (2023-2028)
Table 47. Synthetic Opioids Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global Synthetic Opioids Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America Synthetic Opioids Sales by Type (2017-2022) & (K Pcs)
Table 50. North America Synthetic Opioids Sales by Type (2023-2028) & (K Pcs)
Table 51. North America Synthetic Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Synthetic Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Synthetic Opioids Sales by Application (2017-2022) & (K Pcs)
Table 54. North America Synthetic Opioids Sales by Application (2023-2028) & (K Pcs)
Table 55. North America Synthetic Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Synthetic Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Synthetic Opioids Sales by Country (2017-2022) & (K Pcs)
Table 58. North America Synthetic Opioids Sales by Country (2023-2028) & (K Pcs)
Table 59. North America Synthetic Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Synthetic Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Synthetic Opioids Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Synthetic Opioids Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe Synthetic Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Synthetic Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Synthetic Opioids Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe Synthetic Opioids Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe Synthetic Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Synthetic Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Synthetic Opioids Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe Synthetic Opioids Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe Synthetic Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Synthetic Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Synthetic Opioids Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific Synthetic Opioids Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific Synthetic Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Synthetic Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Synthetic Opioids Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific Synthetic Opioids Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific Synthetic Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Synthetic Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Synthetic Opioids Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific Synthetic Opioids Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific Synthetic Opioids Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Synthetic Opioids Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Synthetic Opioids Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America Synthetic Opioids Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America Synthetic Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Synthetic Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Synthetic Opioids Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America Synthetic Opioids Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America Synthetic Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Synthetic Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Synthetic Opioids Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America Synthetic Opioids Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America Synthetic Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Synthetic Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Synthetic Opioids Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Synthetic Opioids Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Synthetic Opioids Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Synthetic Opioids Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Synthetic Opioids Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Synthetic Opioids Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Synthetic Opioids Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Synthetic Opioids Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Synthetic Opioids Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa Synthetic Opioids Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa Synthetic Opioids Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Synthetic Opioids Revenue by Country (2023-2028) & (US$ Million)
Table 109. Purdue Pharma Corporation Information
Table 110. Purdue Pharma Description and Major Businesses
Table 111. Purdue Pharma Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Purdue Pharma Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Purdue Pharma Recent Developments
Table 114. Pfizer Corporation Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Pfizer Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Pfizer Recent Developments
Table 119. Janssen Pharmaceuticals Corporation Information
Table 120. Janssen Pharmaceuticals Description and Major Businesses
Table 121. Janssen Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Janssen Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Janssen Pharmaceuticals Recent Developments
Table 124. Teva Pharmaceuticals Corporation Information
Table 125. Teva Pharmaceuticals Description and Major Businesses
Table 126. Teva Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Teva Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Teva Pharmaceuticals Recent Developments
Table 129. Endo International Corporation Information
Table 130. Endo International Description and Major Businesses
Table 131. Endo International Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 132. Endo International Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Endo International Recent Developments
Table 134. West-Ward Pharmaceuticals Corporation Information
Table 135. West-Ward Pharmaceuticals Description and Major Businesses
Table 136. West-Ward Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 137. West-Ward Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. West-Ward Pharmaceuticals Recent Developments
Table 139. Mallinckrodt Pharmaceuticals Corporation Information
Table 140. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 141. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 142. Mallinckrodt Pharmaceuticals Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Mallinckrodt Pharmaceuticals Recent Developments
Table 144. Mylan Corporation Information
Table 145. Mylan Description and Major Businesses
Table 146. Mylan Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 147. Mylan Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Mylan Recent Developments
Table 149. Impax Laboratories Corporation Information
Table 150. Impax Laboratories Description and Major Businesses
Table 151. Impax Laboratories Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 152. Impax Laboratories Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Impax Laboratories Recent Developments
Table 154. Indivior Corporation Information
Table 155. Indivior Description and Major Businesses
Table 156. Indivior Synthetic Opioids Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 157. Indivior Synthetic Opioids Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Indivior Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Synthetic Opioids Distributors List
Table 162. Synthetic Opioids Customers List
Table 163. Synthetic Opioids Market Trends
Table 164. Synthetic Opioids Market Drivers
Table 165. Synthetic Opioids Market Challenges
Table 166. Synthetic Opioids Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Synthetic Opioids Product Picture
Figure 3. Global Synthetic Opioids Market Share by Type in 2021 & 2028
Figure 3. Methadone Product Picture
Figure 4. Fentanyl Product Picture
Figure 5. Meperidine Product Picture
Figure 6. Hydrocodone Product Picture
Figure 7. Oxymorphone Product Picture
Figure 8. Oxycodone Product Picture
Figure 9. Global Synthetic Opioids Market Share by Application in 2021 & 2028
Figure 10. Pain Management
Figure 11. De-addiction
Figure 12. Synthetic Opioids Report Years Considered
Figure 13. Global Synthetic Opioids Sales 2017-2028 (K Pcs)
Figure 14. Global Synthetic Opioids Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Synthetic Opioids Revenue 2017-2028 (US$ Million)
Figure 16. Global Synthetic Opioids Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Synthetic Opioids Sales Market Share by Region (2017-2022)
Figure 18. Global Synthetic Opioids Sales Market Share by Region (2023-2028)
Figure 19. North America Synthetic Opioids Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Synthetic Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Synthetic Opioids Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Synthetic Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Synthetic Opioids Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Synthetic Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Synthetic Opioids Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Synthetic Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Synthetic Opioids Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Synthetic Opioids Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Synthetic Opioids Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Synthetic Opioids in the World: Market Share by Synthetic Opioids Revenue in 2021
Figure 31. Global Synthetic Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Synthetic Opioids Sales Market Share by Type (2017-2028)
Figure 33. Global Synthetic Opioids Revenue Market Share by Type (2017-2028)
Figure 34. Global Synthetic Opioids Sales Market Share by Application (2017-2028)
Figure 35. Global Synthetic Opioids Revenue Market Share by Application (2017-2028)
Figure 36. North America Synthetic Opioids Sales Market Share by Type (2017-2028)
Figure 37. North America Synthetic Opioids Revenue Market Share by Type (2017-2028)
Figure 38. North America Synthetic Opioids Sales Market Share by Application (2017-2028)
Figure 39. North America Synthetic Opioids Revenue Market Share by Application (2017-2028)
Figure 40. North America Synthetic Opioids Sales Share by Country (2017-2028)
Figure 41. North America Synthetic Opioids Revenue Share by Country (2017-2028)
Figure 42. U.S. Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Synthetic Opioids Sales Market Share by Type (2017-2028)
Figure 45. Europe Synthetic Opioids Revenue Market Share by Type (2017-2028)
Figure 46. Europe Synthetic Opioids Sales Market Share by Application (2017-2028)
Figure 47. Europe Synthetic Opioids Revenue Market Share by Application (2017-2028)
Figure 48. Europe Synthetic Opioids Sales Share by Country (2017-2028)
Figure 49. Europe Synthetic Opioids Revenue Share by Country (2017-2028)
Figure 50. Germany Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 51. France Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Synthetic Opioids Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Synthetic Opioids Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Synthetic Opioids Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Synthetic Opioids Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Synthetic Opioids Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Synthetic Opioids Revenue Share by Region (2017-2028)
Figure 61. China Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 64. India Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Synthetic Opioids Sales Market Share by Type (2017-2028)
Figure 72. Latin America Synthetic Opioids Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Synthetic Opioids Sales Market Share by Application (2017-2028)
Figure 74. Latin America Synthetic Opioids Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Synthetic Opioids Sales Share by Country (2017-2028)
Figure 76. Latin America Synthetic Opioids Revenue Share by Country (2017-2028)
Figure 77. Mexico Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Synthetic Opioids Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Synthetic Opioids Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Synthetic Opioids Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Synthetic Opioids Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Synthetic Opioids Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Synthetic Opioids Revenue Share by Country (2017-2028)
Figure 86. Turkey Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Synthetic Opioids Revenue (2017-2028) & (US$ Million)
Figure 89. Synthetic Opioids Value Chain
Figure 90. Synthetic Opioids Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.